Jazz Pharmaceuticals is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases – often with limited or no therapeutic options. Following the recent acquisition of Greenwich Biosciences, together we are continuing our commitment to patients and pursuing innovative and differentiated therapies that establish new or better standards of care in neuroscience and oncology.

For more information, please visit www.jazzpharmaceuticals.com.